108 related articles for article (PubMed ID: 10418215)
21. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
[TBL] [Abstract][Full Text] [Related]
22. Primary malignant lymphomas of the central nervous system: radiotherapy results in 12 cases.
Suh CO; Loh JJ; Kim GE; Kim BS; Choi JU; Chung SS; Lee KC
Yonsei Med J; 1989; 30(1):54-64. PubMed ID: 2741474
[TBL] [Abstract][Full Text] [Related]
23. [Radiation therapy and diagnosis of primary malignant lymphoma of the brain].
Ishino Y; Terashima H; Yamashita S; Tsukamoto Y; Nakata H; Yokota A
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 May; 50(5):519-26. PubMed ID: 2388819
[TBL] [Abstract][Full Text] [Related]
24. Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure.
Michalski JM; Garcia DM; Kase E; Grigsby PW; Simpson JR
Radiology; 1990 Sep; 176(3):855-60. PubMed ID: 2389047
[TBL] [Abstract][Full Text] [Related]
25. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?
O'Neill BP; O'Fallon JR; Earle JD; Colgan JP; Brown LD; Krigel RL
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):663-73. PubMed ID: 7558957
[TBL] [Abstract][Full Text] [Related]
26. Consolidation radiotherapy in primary central nervous system lymphomas: impact on outcome of different fields and doses in patients in complete remission after upfront chemotherapy.
Ferreri AJ; Verona C; Politi LS; Chiara A; Perna L; Villa E; Reni M
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):169-75. PubMed ID: 20584577
[TBL] [Abstract][Full Text] [Related]
27. Primary CNS lymphoma in immunocompetent patients from 1989 to 2001: a retrospective analysis of 164 cases uniformly diagnosed by stereotactic biopsy.
Feuerhake F; Baumer C; Cyron D; Illerhaus G; Olschewski M; Tilgner J; Ostertag CB; Volk B
Acta Neurochir (Wien); 2006 Aug; 148(8):831-8; discussion 838. PubMed ID: 16791439
[TBL] [Abstract][Full Text] [Related]
28. Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain.
Ogawa T; Kanno I; Hatazawa J; Inugami A; Fujita H; Shimosegawa E; Murakami M; Okudera T; Uemura K; Yasui N
Radiographics; 1994 Jan; 14(1):101-10. PubMed ID: 8128041
[TBL] [Abstract][Full Text] [Related]
29. Primary brain lymphomas after kidney transplantation: presentation and outcome.
Snanoudj R; Durrbach A; Leblond V; Caillard S; Hurault De Ligny B; Noel C; Rondeau E; Moulin B; Mamzer-Bruneel MF; Lacroix C; Charpentier B
Transplantation; 2003 Sep; 76(6):930-7. PubMed ID: 14508356
[TBL] [Abstract][Full Text] [Related]
30. Computed tomographic features of primary brain lymphoma.
Barsky MF; Coates RK; Macdonald DR
Can Assoc Radiol J; 1989 Apr; 40(2):80-3. PubMed ID: 2702505
[TBL] [Abstract][Full Text] [Related]
31. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
Singhal D; Witham TF; Germanwala A; Flickinger JC; Schiff D; Kondziolka D
Can J Neurol Sci; 2002 May; 29(2):147-53. PubMed ID: 12035835
[TBL] [Abstract][Full Text] [Related]
32. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
33. Primary central nervous system lymphoma a report of nine cases.
Lakshmaiah KC; Lokanath D; Ramesh C; Babu KG; Rao CR; Swamy K
Indian J Cancer; 1996 Jun; 33(2):103-7. PubMed ID: 8979473
[TBL] [Abstract][Full Text] [Related]
34. [Results of the treatment of malignant lymphoma of the brain--a report of Japan Lymphoma Radiation Therapy Group (JLRTG)].
Niibe H; Tamaki Y; Watanabe S; Masaki N; Horiuchi J; Hayabuchi N; Kaneda K; Morita K
Gan No Rinsho; 1988 Apr; 34(5):651-7. PubMed ID: 3385931
[TBL] [Abstract][Full Text] [Related]
35. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
[TBL] [Abstract][Full Text] [Related]
36. Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases.
Mendenhall NP; Thar TL; Agee OF; Harty-Golder B; Ballinger WE; Million RR
Cancer; 1983 Dec; 52(11):1993-2000. PubMed ID: 6354420
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and neuroimage characteristics of primary central nervous system lymphoma].
Ding XP; Wang JY; Yuan XR; Peng ZF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):451-3. PubMed ID: 16134603
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
Ney DE; Reiner AS; Panageas KS; Brown HS; DeAngelis LM; Abrey LE
Cancer; 2010 Oct; 116(19):4605-12. PubMed ID: 20572045
[TBL] [Abstract][Full Text] [Related]
39. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
Kawamura T; Koga S; Okamoto M; Kanno T; Iwamura H
Radiat Med; 2001; 19(3):145-9. PubMed ID: 11467381
[TBL] [Abstract][Full Text] [Related]
40. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
